| 2024/09/27 08:08:23 | |
|---|---|
| Price | |
| 209.60 EUR | |
| Difference | -1.78% (-3.80) |
General attributes
| ISIN | US45784P1012 |
| Symbol | PODD |
| Exchange | Berlin |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 14,770 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 208.60 EUR (150) |
| Ask (Ask size) | 209.20 EUR (150) |
| Open | 209.60 EUR |
| High | 209.60 EUR |
| Low | 209.60 EUR |
| Close (prev. day) | 213.40 EUR |
| VWAP | - |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: INSULET CORPORATION |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/09/27 |
|
Global Equity Ratings |
|
| 2024/09/11 |
|
Global Equity Ratings |
|
| 2024/09/05 |
|
Global Equity Ratings |
|
| 2024/08/12 |
|
Global Equity Ratings |
|
| 2024/07/24 |
|
Global Equity Ratings |
|
| 2024/09/27 08:08:23 | |
|---|---|
| Price | |
| 209.60 EUR | |
| Difference | -1.78% (-3.80) |
General attributes
| ISIN | US45784P1012 |
| Symbol | PODD |
| Exchange | Berlin |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 14,770 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 208.60 EUR (150) |
| Ask (Ask size) | 209.20 EUR (150) |
| Open | 209.60 EUR |
| High | 209.60 EUR |
| Low | 209.60 EUR |
| Close (prev. day) | 213.40 EUR |
| VWAP | - |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +41.98% | +47.63% | -12.11% |
| Perf (abs.) | +63.10 | +68.85 | -29.40 |
| Beta | 0.89 | 1.15 | 1.25 |
| Volatility | 39.52 | 42.47 | 44.52 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 211.96 EUR (0) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 190.68 EUR (0) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 179.81 EUR (0) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 169.84 EUR (0) |
| YTD High | date | 213.40 EUR (2024/09/26) |
| YTD Low | date | 148.20 EUR (2024/05/14) |
| 52 Weeks High | date | 213.40 EUR (2024/09/26) |
| 52 Weeks Low | date | 120.35 EUR (2023/10/13) |
All listings for INSULET CORPORATION
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/09/26 | 22:26 | 210.70 EUR | 0.01 | 3 |
| Stuttgart | 2024/09/27 | 18:55 | 207.50 EUR | 0.00 | 2 |
| Nasdaq | 2024/09/27 | 20:59 | 233.04 USD | 53.13 | 9,524 |
| Munich | 2024/09/27 | 17:26 | 207.20 EUR | 0.00 | 2 |
| Frankfurt | 2024/09/27 | 19:55 | 207.80 EUR | 0.00 | 6 |
| Duesseldorf | 2024/09/27 | 19:30 | 207.90 EUR | 0.00 | 4 |
| Berlin | 2024/09/27 | 08:08 | 209.60 EUR | 0.00 | 1 |
Company Logo
Contact Details
| INSULET CORP. |
| - - |
| 100 Nagog Park - 01720 Acton |
| Telefon: +1-978-600-7000 |
| Fax: +1-978-600-0120 |
| E-mail: - |
PDF Downloads
| Company report: INSULET CORPORATION | |
Company Profile
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA. |
Members of Management Board
| Timothy Scannell | Chairman of Board of Directors |
| Jessica Hopfield | Member of Board of Directors |
| Luciana Borio | Member of Board of Directors |
| Wayne Frederick | Member of Board of Directors |
| Elizabeth Weatherman | Member of Board of Directors |
| Flavia Pease | Member of Board of Directors |
| Michael Minogue | Member of Board of Directors |
| Timothy Stonesifer | Member of Board of Directors |
| Jim Hollingshead | Chairman of Managing Board |
| Dan Manea | Member of Executive Committee |
| Eric Benjamin | Member of Executive Committee |
| Lauren Budden | Member of Executive Committee |